Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide (Mebendazole)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01729260
Recruitment Status : Completed
First Posted : November 20, 2012
Last Update Posted : May 7, 2021
Sponsor:
Collaborator:
Accelerate Brain Cancer Cure
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 2016
Actual Study Completion Date : April 16, 2021